FIELD: biotechnology.
SUBSTANCE: invention relates to the use of an isolated compound selected from taraxasterol, taraxerol, taraxerone, roburic acid, taraxasterol acetate, taraxeryl acetate, lupenone or a salt thereof, for making a product for controlling or killing Demodex spp mites.
EFFECT: use of the invention enables effective control of Demodex mites.
17 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
CHIRAL DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES | 2016 |
|
RU2732405C2 |
COMBINATION THERAPY USING DIARYL MACROCYCLIC COMPOUNDS | 2018 |
|
RU2784853C2 |
CHIRAL DIARYL MACROCYCLES AND USE THEREOF | 2016 |
|
RU2728579C2 |
CFTR REGULATORS AND THEIR APPLICATION METHODS | 2016 |
|
RU2749834C2 |
OBTAINING SUBSTITUTED ACRYLATE COMPOUND | 2021 |
|
RU2830161C1 |
NOVEL NRP-B AGONISTS | 2010 |
|
RU2557290C2 |
METHODS OF SCREENING TO IDENTIFY THERAPEUTIC CANDIDATES FOR THE TREATMENT OF INTRAOCULAR DISEASES OR DISORDERS | 2019 |
|
RU2795857C2 |
NEW NPR-B AGONISTS | 2010 |
|
RU2636738C2 |
CFTR REGULATORS AND METHODS OF USING | 2016 |
|
RU2730855C2 |
PYRROLO[2,3-b]PYRIDINE DERIVATIVES INHIBITING ACTIVITY OF ANTI-APOPTOTIC Bcl-2 PROTEINS | 2011 |
|
RU2567857C2 |
Authors
Dates
2025-03-24—Published
2021-04-23—Filed